Trust Point Inc. trimmed its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 16.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 3,587 shares of the company’s stock after selling 701 shares during the quarter. Trust Point Inc.’s holdings in Chemed were worth $1,900,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of CHE. Creative Planning lifted its position in shares of Chemed by 2.8% during the 2nd quarter. Creative Planning now owns 1,228 shares of the company’s stock valued at $667,000 after acquiring an additional 34 shares during the period. Sanctuary Advisors LLC bought a new stake in shares of Chemed during the 2nd quarter valued at $1,955,000. Park Avenue Securities LLC bought a new stake in shares of Chemed during the 3rd quarter valued at $260,000. Handelsbanken Fonder AB lifted its position in shares of Chemed by 8.4% during the 3rd quarter. Handelsbanken Fonder AB now owns 3,872 shares of the company’s stock valued at $2,327,000 after acquiring an additional 300 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after buying an additional 52 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In related news, VP Brian C. Judkins purchased 145 shares of Chemed stock in a transaction on Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the transaction, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Spencer S. Lee sold 732 shares of the company’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This trade represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.
Chemed Stock Down 1.0 %
Chemed Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. Chemed’s payout ratio is presently 10.11%.
Analyst Ratings Changes
CHE has been the subject of a number of research analyst reports. Royal Bank of Canada lowered their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.
Check Out Our Latest Report on Chemed
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Recommended Stories
- Five stocks we like better than Chemed
- Compound Interest and Why It Matters When Investing
- How to Invest in Small Cap Stocks
- Buy P&G Now, Before It Sets A New All-Time High
- These Are the Dividend Stocks Insiders Bought in January
- What Are Dividend Challengers?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.